S 1414 119th Congress Senate Health Drug safety, medical device, and laboratory regulation Licensing and registrations Medical research

Expedited Access to Biosimilars Act

Introduced: April 10, 2025 Introduced by: Paul, Rand Republican · Kentucky See on congress.gov

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 27, 2026

Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.

Jul 27, 2026

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Jul 22, 2026

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Apr 10, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Apr 10, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 27, 2026

Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.

Hearings & markups 1

Business meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price t…
Open Business Meeting Jul 22, 2026 · 10:00 AM EDT · Health, Education, Labor, and Pensions Committee

Related & companion bills 1

Bill text 2 versions

Introduced in Senate Formatted Text PDF Formatted XML
Reported to Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Health, Education, Labor, and Pensions Committee
Senate

Lobbying activity 46

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

WHITMER & WORRALL, LLC
for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
BIOTECHNOLOGY INNOVATION ORGANIZATION
for BIOTECHNOLOGY INNOVATION ORGANIZATION · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
COVINGTON & BURLING LLP
for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026
ASSOCIATION FOR ACCESSIBLE MEDICINES
for ASSOCIATION FOR ACCESSIBLE MEDICINES · District of Columbia · 2nd Quarter (Apr 1 - June 30) 2026

See all 46 filings →

Cosponsors 2

Hassan, Margaret Wood

New Hampshire · Jul 20, 2026

Lee, Mike

Utah · Jun 3, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). S. 1414: Expedited Access to Biosimilars Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-1414/

MLA

"S. 1414: Expedited Access to Biosimilars Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-1414/.

Bluebook (legal)

S. 1414, 119th Cong. (2026), https://openamerica.io/bill/119-S-1414/.

Markdown link

[S. 1414: Expedited Access to Biosimilars Act](https://openamerica.io/bill/119-S-1414/)